PMID- 32593669 OWN - NLM STAT- MEDLINE DCOM- 20210728 LR - 20210728 IS - 1879-4076 (Electronic) IS - 1879-4068 (Linking) VI - 12 IP - 1 DP - 2021 Jan TI - Impact of stereotactic body radiation therapy on geriatric assessment and management for older patients with head and neck cancer using G8. PG - 122-127 LID - S1879-4068(20)30176-4 [pii] LID - 10.1016/j.jgo.2020.06.023 [doi] AB - PURPOSE: Management of head and neck cancers (HNC) in older adults is a common but challenging clinical scenario. We assess the impact of Stereotactic Body Radiation Therapy (SBRT) on survival utilizing the Geriatric-8 (G8) questionnaire. MATERIALS AND METHODS: 171 HNC patients, deemed medically unfit for definitive treatment, were treated with SBRT +/- systemic therapy. G8 questionnaires were collected at baseline, at 4-6 weeks, and at 2-3 months post-treatment. Patients were stratified according to their baseline G8 score: <11 as 'vulnerable', 11-14 as 'intermediate', and >14 as 'fit'. Overall survival (OS) was assessed through univariate Kaplan Meier analysis. Repeated measures ANOVA was used to determine if baseline characteristics affected G8 score changes. RESULTS: Median follow-up was seventeen months. 60% of patients presented with recurrent HNC, 30% with untreated HNC primaries, and 10% with metastatic non-HNC primaries. Median age was 75 years. Median Charlson Comorbidity Index score was 2. 51% of patients were 'vulnerable', 37% were 'intermediate', and 12% were 'fit' at baseline, with median survival of 13.2, 24.3, and 41.0 months, respectively (p = .004). Patients who saw a decrease in their follow-up G8 score (n = 69) had significantly lower survival than patients who had stable or increased follow-up G8 scores (n = 102), with median survival of 8.6 vs 36.0 months (p < .001). CONCLUSION: The G8 questionnaire may be a useful tool in upfront treatment decision-making to predict prognosis and prevent older patients from receiving inappropriate anti-cancer treatment. Decline in follow-up G8 scores may also predict worse survival and aid in goals of care following treatment. CI - Copyright (c) 2020 Elsevier Inc. All rights reserved. FAU - Gogineni, Emile AU - Gogineni E AD - Department of Radiation Medicine, Northwell Health, Lake Success, NY, USA. FAU - Rana, Zaker AU - Rana Z AD - Department of Radiation Medicine, Northwell Health, Lake Success, NY, USA. FAU - Wotman, Michael AU - Wotman M AD - Department of Radiation Medicine, Northwell Health, Lake Success, NY, USA. FAU - Karten, Jessie AU - Karten J AD - Department of Radiation Medicine, Northwell Health, Lake Success, NY, USA. FAU - Riegel, Adam AU - Riegel A AD - Department of Radiation Medicine, Northwell Health, Lake Success, NY, USA. FAU - Marrero, Mihaela AU - Marrero M AD - Department of Radiation Medicine, Northwell Health, Lake Success, NY, USA. FAU - Maduro, Luis AU - Maduro L AD - Department of Radiation Medicine, Northwell Health, Lake Success, NY, USA. FAU - Kamdar, Dev AU - Kamdar D AD - Department of Otolarygology, Head / Neck Surgery, Northwell Health, Lake Success, NY, USA. FAU - Frank, Douglas AU - Frank D AD - Department of Otolarygology, Head / Neck Surgery, Northwell Health, Lake Success, NY, USA. FAU - Paul, Doru AU - Paul D AD - Department of Medical Oncology, Northwell Health, Lake Success, NY, USA. FAU - Seetharamu, Nagashree AU - Seetharamu N AD - Department of Medical Oncology, Northwell Health, Lake Success, NY, USA. FAU - Ghaly, Maged AU - Ghaly M AD - Department of Radiation Medicine, Northwell Health, Lake Success, NY, USA. Electronic address: mghaly@northwell.edu. LA - eng PT - Journal Article DEP - 20200624 PL - Netherlands TA - J Geriatr Oncol JT - Journal of geriatric oncology JID - 101534770 SB - IM MH - Aged MH - Geriatric Assessment MH - *Head and Neck Neoplasms/radiotherapy MH - Humans MH - Neoplasm Recurrence, Local MH - *Radiosurgery MH - Surveys and Questionnaires OTO - NOTNLM OT - Cancer OT - Elderly OT - G8 OT - Head neck OT - Older OT - Prognosis OT - Quality of life OT - SBRT OT - Screening tool COIS- Declaration of Competing Interest Conflicts of interest: none. EDAT- 2020/07/01 06:00 MHDA- 2021/07/29 06:00 CRDT- 2020/06/29 06:00 PHST- 2020/04/06 00:00 [received] PHST- 2020/05/11 00:00 [revised] PHST- 2020/06/18 00:00 [accepted] PHST- 2020/07/01 06:00 [pubmed] PHST- 2021/07/29 06:00 [medline] PHST- 2020/06/29 06:00 [entrez] AID - S1879-4068(20)30176-4 [pii] AID - 10.1016/j.jgo.2020.06.023 [doi] PST - ppublish SO - J Geriatr Oncol. 2021 Jan;12(1):122-127. doi: 10.1016/j.jgo.2020.06.023. Epub 2020 Jun 24.